Correlation Between Syndax Pharmaceuticals and Bright Minds

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and Bright Minds Biosciences, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Bright Minds.

Diversification Opportunities for Syndax Pharmaceuticals and Bright Minds

0.15

Correlation Coefficient

Syndax Pharmaceuticals  Bright Minds

Average diversification

The 3 months correlation between Syndax and Bright is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Bright Minds go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Bright Minds

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.64 times more return on investment than Bright Minds. However, Syndax Pharmaceuticals is 1.57 times less risky than Bright Minds. It trades about 0.04 of its potential returns per unit of risk. Bright Minds Biosciences is currently generating about -0.01 per unit of risk. If you would invest  1,293  in Syndax Pharmaceuticals on December 26, 2024 and sell it today you would earn a total of  51.00  from holding Syndax Pharmaceuticals or generate 3.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  Bright Minds Biosciences

Syndax Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, Syndax Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Bright Minds Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bright Minds Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Bright Minds is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Syndax Pharmaceuticals and Bright Minds

The main advantage of trading using opposite Syndax Pharmaceuticals and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.

The idea behind Syndax Pharmaceuticals and Bright Minds Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.